Nadk | NAD kinase
Physiological systems
20 / 24 physiological systems tested
4 Significantly impacted by the knock-out
Adipose tissue Growth/size/body region Skeleton Mortality/aging
16 No significant impact
4 Not tested
Data collections
Gene metrics:5Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| preweaning lethality, complete penetrance | 3 supporting datasets | Nadkem2(IMPC)Bay | homozygote | Early adult | N/A * | ||
| increased bone mineral content | 1 supporting dataset | Nadkem2(IMPC)Bay | heterozygote | Early adult | 2.74x10-5 | ||
| embryonic lethality prior to organogenesis | 1 supporting dataset | Nadkem2(IMPC)Bay | homozygote | E9.5 | N/A * | ||
| increased lean body mass | 1 supporting dataset | Nadkem2(IMPC)Bay | heterozygote | Early adult | 9.37x10-6 | ||
| decreased total body fat amount | 1 supporting dataset | Nadkem2(IMPC)Bay | heterozygote | Early adult | 2.06x10-5 |
| | | | | | | | | | |
External links
No external links available for Nadk.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
| Nadkem1(IMPC)Bay | | mouse | |
| Nadkem2(IMPC)Bay | Exon Deletion | | mouse |
| Nadktm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
| Nadktm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | | ES Cell |